Gliomas represent over 30% of all CNS tumors and over 80% of malignant brain tumors. In this webinar, Dr. Carolyn Marks Research Scientist, Protein Technologies, R&D, at Atlas antibodies, discusses recent advances in our understanding of gliomas, starting from a short history and evolution of glioma classification, the diagnostic and therapeutic challenges, and the molecular markers useful for tissue and cell analysis.
Негізгі бет Ғылым және технология Glioma Biology and Molecular Markers
Пікірлер